BioChange has developed a breakthrough technology for tissue regeneration. A unique injectable scaffold that stimulates tissue repair and remodelling at the injected site. The scaffold is based on natural biomaterials designed for implantation using a minimally invasive procedure. It mimics the healthy Extra Cellular Matrix (ECM) and triggers the body to repair itself. 
Multiple long-term animal studies confirmed the safety and efficacy of the technology. The company is now selling products in the veterinary market and in tissue engineering research and is committed to start first clinical study in aesthetic dermatology in 2022. 
Several other products based on the CellFoam platform technology are in development to enrich our pipeline.

Biotechnology

Health Care

BioChange Ltd.

Ishay Attar

Yuval Eitan

Keren Sinik

Ofir Artzi

Mauro Wjuniski

Rina Lev

Sonya Schneier

Michal Graff

Eran Gefen

The Advisory Board at BioChange Ltd. provides strategic guidance and expert advice on the development and commercialization of the company's tissue regeneration technologies. Comprising experienced professionals in relevant fields, the board helps steer clinical studies, regulatory compliance, market entry strategies, and overall R&D direction to ensure the success and growth of the company's innovative pipeline.

Advisory Board

The Leadership Team at BioChange Ltd. is responsible for setting the strategic direction and vision of the company, ensuring the successful development and commercialization of their tissue regeneration technology. They oversee the operational, medical, and technological aspects of the business, driving innovation, managing clinical studies, and expanding the product pipeline into new markets.

Leadership Team

The Research and Development team at BioChange Ltd. is responsible for innovating and refining tissue regeneration technologies. They conduct experimental research, develop new product prototypes based on the CellFoam platform, and validate the safety and efficacy of these technologies through rigorous testing. The team closely collaborates to ensure that new products meet the required standards for anticipated clinical studies and market applications.

BioChange Ltd.

Org chart

Board & advisors

Teams

Advisory Board

Leadership Team

Research and Development

Offices

BioChange Ltd.

Org chart

Board & advisors

Teams

Advisory Board

Leadership Team

Research and Development

Offices

Related companies